Bioeconomy

To understand the range of governmental priorities for the bioeconomy, we spoke with key agencies represented on the National Bioeconomy Board to collect their perspectives.

We sat down with Congressman Jake Auchincloss to get a better understanding of how Congress and the Select Committee on the CCP view the need for standards for the bioeconomy.

In the quest for sustainable energy and materials, biomass emerges as a key player, bridging the gap between the energy sector and the burgeoning U.S. and regional bioeconomies.

Multiple bioeconomy-related programs were authorized through the bipartisan CHIPS & Science legislation but have yet to receive anywhere near their funding targets.

Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.

While the U.S. government grapples with the definition of the bioeconomy and what sectors it does and does not contain, another definitional issue needs to be addressed: What does sustainability mean in a bioeconomy?

Public trust is the key to unlocking the full potential of the bioeconomy. Without it, the U.S. may fall short of long-term economic goals and biotech leadership.

We’ve created a living table to track progress on the Bioeconomy EO, enhance accountability, and follow the state of the U.S. bio economy as it evolves.

Five federal policy recommendations to maximize opportunity and minimize risk at the intersection of biology and artificial intelligence

The landscape of biosecurity risks related to AI is complex and rapidly changing, and understanding the range of issues requires diverse perspectives and expertise. Here are five promising ideas that match the diversity of challenges that AI poses in the life sciences.

The future of industrial growth resides in the establishment of biotechnology as a new pillar of industrial domestic manufacturing. Here’s how BioNETWORK will advance domestic biomanufacturing.

September should be bioeconomy month. To celebrate, we took our experts to the Hill to share their research and recommendations with Congress.

We sat down with MicroByre CEO Dr. Sarah Richardson to talk about biomanufacturing, corn sugar’s pitfalls, and more.

To develop an overarching framework that includes addressing bio-related risks, Congress, federal agencies, and non-governmental AI stakeholders must work together.

To achieve a durable and strategic interagency approach to the bioeconomy, OSTP should establish a Bioeconomy Initiative Coordination Office to coordinate strategic U.S. government investments in the bioeconomy.

For the U.S. bioeconomy to prosper and boom, the U.S. needs to land on a single, working definition of the bioeconomy while considering the role of sustainability in order to be competitive at the global scale.

The U.S. is facing a shortage in both pilot-scale and manufacturing-scale biomanufacturing facilities that severely hinders product development and commercialization.

Amino acids are essential but costly inputs for large-scale bioproduction. Federal funding can incentivize scalable production, cutting these costs in half.

Here are industry leaders’ top three takeaways from this year’s Advanced Bioeconomy Leadership Conference.

The past year has been an exciting time for the bioeconomy as U.S. government agencies work to update their approaches and improve coordination to better support bio-based products and processes.

The COVID-19 pandemic has highlighted the essential importance of biomanufacturing capabilities—extending to the geopolitical level—as well as the fragility of many supply chains and processes.

The U.S. government should create a Bio for America Program Office (BAPO) at the National Institute for Standards and Technology (NIST) to house a suite of initiatives that would lead to the creation of more well-paying U.S.-based biomanufacturing jobs and more.

Streamlined funding of open and cross-disciplinary research, prize and challenge mechanisms, and market shaping through innovative procurement have all proven highly effective in the face of market failures and applied technology gaps like those seen in our bioindustry.

Plants are key to enable a diversified and climate-resilient food system. Mary Fernandes proposes a Plant Genome Project (PGP), a robust Human Genome Project-style initiative to build a dataset of genetic information on plant species.

Congress had a lot more on its agenda than semiconductors when compiling the CHIPS and Science Act of 2022. The bill–law as of yesterday–puts forward an expansive framework to advance U.S. innovation broadly, including in areas that feed into a critical sector: the bioeconomy. 

The federal government can accelerate capabilities and applications of environmental biotechnology by establishing the CLimate Improvements through Modern Biotechnology (CLIMB) Center.

This is the ideal time to expand U.S. climate strategy into an “all of the above” solution that includes carbon capture and storage as a core component.